Skip to main navigation
  • Our Science
  • AT-527
  • COVID-19
  • About Atea
    • About Us
    • Pipelines & Programs
    • Leadership
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
      • Publications
    • Financials
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Info
      • Stock Quote & Chart
      • Historical Price Look up
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Careers
  • Contact
The tip of a pipette pointing towards droplets suspended in a green solution.

Investor Relations

Annual Reports

Breadcrumb

  1. Investors
  2. Annual Reports

Annual Reports

February 28, 2022
2021 Form 10-K 5.4 MB
March 30, 2021
2020 Form 10-K 3.8 MB
Investor FAQs
RSS Feeds
Email Alerts
Contact IR

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

  • Atea Pharmaceuticals, Inc.
  • 225 Franklin Street
  • Suite 2100
  • Boston, MA 02110
  • (857) 284-8891

Copyright © 2023 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use